ResMed Inc Director Proposes Sale of Common Shares

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an update.

ResMed Inc has filed a Form 144 indicating a proposed sale of securities under Rule 144 of the Securities Act of 1933. The filing involves the sale of 2,000 common shares by Peter C. Farrell, a director of the company, with an aggregate market value of $500,000. The transaction reflects insider activity and may have implications for the company’s stock performance and investor perceptions.

The most recent analyst rating on (AU:RMD) stock is a Buy with a A$33.70 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.

More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep disorders, such as sleep apnea, and chronic respiratory diseases. The company is known for its innovative solutions in sleep and respiratory care, catering to a global market.

Average Trading Volume: 1,299,233

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$55.74B

See more insights into RMD stock on TipRanks’ Stock Analysis page.